Role of promoter hypermethylation in Cisplatin treatment response of male germ cell tumors

BACKGROUND: Male germ cell tumor (GCT) is a highly curable malignancy, which exhibits exquisite sensitivity to cisplatin treatment. The genetic pathway(s) that determine the chemotherapy sensitivity in GCT remain largely unknown. RESULTS: We studied epigenetic changes in relation to cisplatin respon...

Descripción completa

Detalles Bibliográficos
Autores principales: Koul, Sanjay, McKiernan, James M, Narayan, Gopeshwar, Houldsworth, Jane, Bacik, Jennifer, Dobrzynski, Deborah L, Assaad, Adel M, Mansukhani, Mahesh, Reuter, Victor E, Bosl, George J, Chaganti, Raju SK, Murty, Vundavalli VVS
Formato: Texto
Lenguaje:English
Publicado: BioMed Central 2004
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC420487/
https://www.ncbi.nlm.nih.gov/pubmed/15149548
http://dx.doi.org/10.1186/1476-4598-3-16

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC420487/
https://www.ncbi.nlm.nih.gov/pubmed/15149548
http://dx.doi.org/10.1186/1476-4598-3-16

Ejemplares similares